Selective GH release
Raun 1998 showed that ipamorelin elicits GHRP-style GH release in rats and swine without raising ACTH, cortisol, or prolactin even at doses >200x the GH ED50 — a selectivity profile no other GHRP shares. This is the foundational mechanistic claim for ipamorelin's modern positioning as a 'cleaner' GHRP.
0 human studies · 8 animal studies
Key findings & citations
- GH release potency in rats/swine comparable to GHRP-6 but without cortisol or prolactin elevation.
- Selectivity holds at doses >200x the ED50 for GH.
- Mechanism: GHS-R1a agonism (ghrelin receptor) without off-target H1/H2 receptor activity.
Top citations
Our take
The cleanest GHRP we have, and the reason ipamorelin became the default partner for GHRH analogs in modern stacks.





